All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low Grade Neoplasms: A Case with a Highly Increased Proliferation Rate

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F24%3AN0000014" target="_blank" >RIV/27283933:_____/24:N0000014 - isvavai.cz</a>

  • Alternative codes found

    RIV/00023001:_____/24:00084917

  • Result on the web

    <a href="https://pubmed.ncbi.nlm.nih.gov/38403790/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/38403790/</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s12022-024-09802-7" target="_blank" >10.1007/s12022-024-09802-7</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Pancreatic Neuroendocrine Microtumors (WHO 2022) Are Not Always Low Grade Neoplasms: A Case with a Highly Increased Proliferation Rate

  • Original language description

    Traditionally considered non-functional low proliferative benign neuroendocrine proliferations measuring less than 5 mm, pancreatic (neuro)endocrine microadenomas are now classifed as pancreatic neuroendocrine microtumors in the 2022 WHO classifcation of endocrine and neuroendocrine tumors. This case report discussed the features of an incidentally identifed 4.7-mm glucagon-expressing pancreatic neuroendocrine microtumor with MEN1 mutation only, chromosomally stable and an epigenetic alpha-like phenotype. The tumor was associated with an unexplained increased proliferation rate in Ki-67 of 15%. There was no associated DAXX/ATRX defciency. The presented case challenges the conventional thought of a low proliferative disease of the so-called “pancreatic neuroendocrine microadenomas” and provides additional support to the 2022 WHO classifcation that also requires grading of these neoplasms. Despite exhibiting molecular features of less aggressive behavior, the case also underscores the biological complexity of pancreatic neuroendocrine microtumors. By recognizing the heterogenous spectrum of neuroendocrine neoplasms, the current case also contributes to ongoing discussions on how to optimize the clinical management of such tumors.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30109 - Pathology

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Endocrine Pathology

  • ISSN

    1046-3976

  • e-ISSN

    1559-0097

  • Volume of the periodical

    35

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    8

  • Pages from-to

    147-153

  • UT code for WoS article

    001170279400001

  • EID of the result in the Scopus database

    2-s2.0-85185972541